Heidi Hunter

Heidi Hunter serves on multiple boards, including IO Biotech, Bavarian Nordic, Sutro Biopharma, and Vicore Pharma, where involvement spans various aspects of clinical stage pharmaceutical development focused on rare diseases. Hunter's experience includes strategic advisory roles and senior executive positions, notably as President of Cardinal Health Specialty Solutions and SVP at both UCB and Boehringer Ingelheim. With a strong academic background, including an MBA from The University of Chicago Booth School of Business and a BA in Economics from the University of Michigan, Heidi Hunter has built a robust career in the biopharmaceutical industry.